Wits RHI Contributes to JNCI Monographs on Single-Dose HPV Vaccination

Wits RHI is excited to announce our contribution to a groundbreaking resource on the state of the science surrounding single-dose vaccination. The newly released HPV Vaccine Monograph, featuring insights from our Research Team and other global experts, explores this critical area of research.

This monograph holds particular significance for Wits RHI as our Research Team is currently leading the HOPE II Study, which investigates the single-dose HPV vaccine among women living with HIV. Participant recruitment for this study is ongoing.

For more information:

• JNCI Monographs Link: Volume 2024 Issue 67 | JNCI Monographs | Oxford Academic
• Research Team Publication: Impact of Single-Dose HPV Vaccination on HPV 16 and 18 Prevalence in South African Adolescent Girls with and without HIV | JNCI Monographs | Oxford Academic
• Summary of JNCI Monograph: State of the Science of Single-Dose Prophylactic HPV Vaccination
• Access the Full Publication: State of the Science of Single-Dose Prophylactic HPV Vaccination

Together, the papers in this monograph strengthen earlier findings: single-dose HPV vaccination offers robust protection against cancer-causing HPV infections globally, with the added benefits of reducing program costs and expanding coverage.